This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Device | Covera™ Vascular Covered Stent |
Generic Name | System, Endovascular Graft, Arteriovenous (av) Dialysis Access Circuit Stenosis Treatment |
Applicant | C.R. Bard, Inc1625 W. 3rd Streettempe, AZ 85528 PMA NumberP170042 Supplement NumberS011 Date Received08/20/2021 Decision Date03/24/2022 Product Code PFV Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No |
Date Received | 2021-08-20 |
Decision Date | 2022-03-24 |
PMA | P170042 |
Supplement | S011 |
Product Code | PFV |
Advisory Committee | Cardiovascular |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Labeling Change - Pas |
Expedited Review | No |
Combination Product | No |
Applicant Address | C.R. Bard, Inc 1625 W. 3rd Street tempe, AZ 85528 PMA NumberP170042 Supplement NumberS011 Date Received08/20/2021 Decision Date03/24/2022 Product Code PFV Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No Combination ProductNo Approval Order Statement approval For An Update To The Labeling To Include The 36-month Data On Patients Enrolled In The AVeNEW IDE Extended Follow-up Study (PAS001) |
Supplement Number | Date | Supplement Type |
---|---|---|
P170042 | Original Filing | |
S012 | 2023-01-06 | 30-day Notice |
S011 | 2021-08-20 | Normal 180 Day Track No User Fee |
S010 | 2021-07-09 | 30-day Notice |
S009 | 2021-05-04 | 30-day Notice |
S008 | 2020-09-01 | 30-day Notice |
S007 | 2020-08-31 | 30-day Notice |
S006 | 2020-08-03 | 30-day Notice |
S005 | ||
S004 | ||
S003 | 2019-04-01 | Normal 180 Day Track No User Fee |
S002 | 2018-09-04 | Panel Track |
S001 | 2018-08-20 | Special (immediate Track) |